Aleksandra Rizo

EVP, Chief Medical Officer, Geron Corporation.

Companies

Syndax Pharmaceuticals IncBoard member May 16, 2024 to now¹
Geron CorporationEVP, Chief Medical Officer Feb 1, 2019 to Feb 18, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Syndax Pharmaceuticals Inc SNDX49,000 shares³$639.7K at $13.05Feb 4, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 4, 2026Granted 24,000 shares of Syndax Pharmaceuticals Inc³
Feb 5, 2025Granted 25,000 shares of Syndax Pharmaceuticals Inc⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSyndax Pharmaceuticals Inc, Board member
2
SEC EDGARGeron Corporation, EVP, Chief Medical Officer
3
SEC EDGARSyndax Pharmaceuticals Inc shares after the filing of Feb 4, 2026
4
SEC EDGARForm 4 filed Feb 7, 2025